We partner with the media to inform the public of the global human crisis.
November 2, 2017Q3 / YTD 2017 Financial Results...
October 31, 2017FDA Advisory Committees Recommend Approval of Indivior’s RBP-6000 for the Treatment of Opioid Use Disorder...
October 3, 2017FDA Posts Advisory Committee Meeting Notice for RBP-6000 NDA...
October 2, 2017Indivior Submits New Drug Application to U.S. FDA for RBP-7000 Risperidone Monthly Depot for Treatment of Schizophrenia...
September 27, 2017Indivior Chief Medical Officer Ponni Subbiah, M.D., Provides Testimony Before the Presidential Commission on Combating Drug Addiction and the Opioid Crisis...
Global Media Contacts
EMEA, Australasia and China Financial Disclosure Reporting
Disclosure Of Payments, Donations & Joint Working
The Online Press Kit is designed to help media research our company for background information or follow-up stories. Please visit the links below to learn more.
About Indivior PLC – An overview of Indivior, including our worldwide locations and key products
Board of Directors – Biographies of Indivior’s Board
The Indivior PLC Pipeline – Information about the Indivior R&D efforts and progress of medicines in the pipeline